edoc

Items where Division is "09 Associated Institutions > Swiss Tropical and Public Health Institute (Swiss TPH) > Department of Medicine (MED) > Clinical Operations (Reus)"

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Date | Item Type | Creators | Refereed
Jump to: Yes
Number of items at this level: 13.

Yes

Dolley, D. and Du Randt, R. and Puhse, U. and Gerber, M. and Bosma, J. and Aerts, A. and Adams, L. and Arnaiz, P. and Joubert, N. and Müller, I. and Nqweniso, S. and Seelig, H. and Steinmann, P. and Utzinger, J. and Walter, C.. (2023) Relationship between body mass index and physical activity among children from low-income communities in Gqeberha, South Africa: a cross-sectional study. Int J Environ Res Public Health, 20 (2). p. 1428.

Mesu, V. K. B. K. and Kalonji, W. M. and Rembry, S. and Valverde Mordt, O. and Ngolo Tete, D. and Prêtre, A. and Delhomme, S. and Ilunga Wa Kyhi, M. and Camara, M. and Catusse, J. and Schneitter, S. and Nusbaumer, M. and Mwamba Miaka, E. and Mahenzi Mbembo, H. and Makaya Mayawula, J. and Layba Camara, M. and Akwaso Massa, F. and Kaninda Badibabi, L. and Kasongo Bonama, A. and Kavunga Lukula, P. and Mutanda Kalonji, S. and Mariero Philemon, P. and Mokilifi Nganyonyi, R. and Embana Mankiara, H. and Asuka Akongo Nguba, A. and Kobo Muanza, V. and Mulenge Nasandhel, E. and Fifi Nzeza Bambuwu, A. and Scherrer, B. and Strub-Wourgaft, N. and Tarral, A.. (2023) Efficacy and safety of acoziborole in patients with human African trypanosomiasis caused by Trypanosoma brucei gambiense: a multicentre, open-label, single-arm, phase 2/3 trial. The Lancet infectious diseases, 23 (4). pp. 463-470.

Berry, C. and du Cros, P. and Fielding, K. and Gajewski, S. and Kazounis, E. and McHugh, T. D. and Merle, C. and Motta, I. and Moore, D. A. J. and Nyang'wa, B. T.. (2022) TB-PRACTECAL: study protocol for a randomised, controlled, open-label, phase II-III trial to evaluate the safety and efficacy of regimens containing bedaquiline and pretomanid for the treatment of adult patients with pulmonary multidrug-resistant tuberculosis. Trials, 23. p. 484.

Kande Betu Kumesu, V. and Mutombo Kalonji, W. and Bardonneau, C. and Valverde Mordt, O. and Ngolo Tete, D. and Blesson, S. and Simon, F. and Delhomme, S. and Bernhard, S. and Nganzobo Ngima, P. and Mahenzi Mbembo, H. and Fina Lubaki, J. P. and Lumeya Vuvu, S. and Kuziena Mindele, W. and Ilunga Wa Kyhi, M. and Mandula Mokenge, G. and Kaninda Badibabi, L. and Kasongo Bonama, A. and Kavunga Lukula, P. and Lumbala, C. and Scherrer, B. and Strub-Wourgaft, N. and Tarral, A.. (2022) Safety and efficacy of oral fexinidazole in children with gambiense human African trypanosomiasis: a multicentre, single-arm, open-label, phase 2-3 trial. Lancet Glob Health, 10 (11). e1665-e1674.

Bosch-Capblanch, X. and O'Donnell, D. and Krause, L. K. and Auer, C. and Oyo-It, A. and Samba, M. and Matsinhe, G. and Garba, A. B. and Rodríguez, D. and Zuske, M. and Njepuome, A. N. and Lee, S. M. M. and Ross, A. and Gajewski, S. and MUloliwa, A. M. and Yapi, R. B. and Brown, D. W.. (2021) Researching, co-creating and testing innovations in paper-based health information systems (PHISICC) to support health workers' decision-making: protocol of a multi-country, transdisciplinary, mixed-methods research programme in three sub-Saharan countries. Health Res Policy Syst, 19. p. 112.

Bosch-Capblanch, X. and Oyo-Ita, A. and Muloliwa, A. M. and Yapi, R. B. and Auer, C. and Samba, M. and Gajewski, S. and Ross, A. and Krause, L. K. and Ekpenyong, N. and Nwankwo, O. and Njepuome, A. N. and Lee, S. M. and Sacarlal, J. and Madede, T. and Berté, S. and Matsinhe, G. and Garba, A. B. and Brown, D. W.. (2021) Does an innovative paper-based health information system (PHISICC) improve data quality and use in primary healthcare? Protocol of a multicountry, cluster randomised controlled trial in sub-Saharan African rural settings. BMJ Open, 11 (7). e051823.

Brand, M. and Wang, L. and Agnello, S. and Gazzola, S. and Gall, F. M. and Raguz, L. and Kaiser, M. and Schmidt, R. S. and Ritschl, A. and Jelk, J. and Hemphill, A. and Mäser, P. and Butikofer, P. and Adams, M. and Riedl, R.. (2021) Antiprotozoal structure-activity relationships of synthetic leucinostatin derivatives and elucidation of their mode of action. Angewandte Chemie, 60 (28). pp. 15613-15621.

Kümmerle, A. and Schmid, C. and Bernhard, S. and Kande, V. and Mutombo, W. and Ilunga, M. and Lumpungu, I. and Mutanda, S. and Nganzobo, P. and Tete, D. N. and Kisala, M. and Burri, C. and Blesson, S. and Valverde Mordt, O.. (2021) Effectiveness of Nifurtimox Eflornithine Combination Therapy (NECT) in T. b. gambiense second stage sleeping sickness patients in the Democratic Republic of Congo: report from a field study. PLoS Negl Trop Dis, 15 (11). e0009903.

Mahende, M. K. and Huber, E. and Kourany-Lefoll, E. and Ali, A. and Hayward, B. and Bezuidenhout, D. and Bagchus, W. and Kabanywanyi, A. M.. (2021) Comparative palatability of orally disintegrating tablets (ODTs) of praziquantel (L-PZQ and Rac-PZQ) versus current PZQ tablet in African children: a randomized, single-blind, crossover study. PLoS Negl Trop Dis, 15 (6). e0007370.

Mesu, V. K. B. K. and Mutombo Kalonji, W. and Bardonneau, C. and Valverde Mordt, O. and Ngolo Tete, D. and Blesson, S. and Simon, F. and Delhomme, S. and Bernhard, S. and Mahenzi Mbembo, H. and Mpia Moke, C. and Lumeya Vuvu, S. and Mudji E'kitiak, J. and Akwaso Masa, F. and Mukendi Ilunga, M. and Mpoyi Muamba Nzambi, D. and Mayala Malu, T. and Kapongo Tshilumbwa, S. and Botalema Bolengi, F. and Nkieri Matsho, M. and Lumbala, C. and Scherrer, B. and Strub-Wourgaft, N. and Tarral, A.. (2021) Oral fexinidazole for stage 1 or early stage 2 African Trypanosoma brucei gambiense trypanosomiasis: a prospective, multicentre, open-label, cohort study. Lancet Glob Health, 9 (7). e999-e1008.

Vanobberghen, F. and Lweno, O. and Kümmerle, A. and Mwebi, K. D. and Asilia, P. and Simon, B. and Mswata, S. and Schmidlin, S. and Glass, T. R. and Daubenberger, C. and Tanner, M. and Meyer-Monard, S.. (2021) Efficacy and safety of intravenous ferric carboxymaltose compared with oral iron for the treatment of iron deficiency anaemia in women after childbirth in Tanzania: a parallelgroup, open-label, randomised controlled phase 3 trial. Lancet Glob Health, 9 (2). e189-e198.

Brown, Jennifer Anne and Ringera, Isaac and Luoga, Ezekiel and Cheleboi, Molisana and Kimera, Namvua and Muhairwe, Josephine and Kayembe, Buntshi Paulin and Molapo Hlasoa, Mosa and Kabundi, Lorraine and Yav, Ching Wey David and Mothobi, Buoang and Thahane, Lineo and Amstutz, Alain and Bachmann, Nadine and Mollel, Getrud Joseph and Bresser, Moniek and Glass, Tracy Renée and Paris, Daniel Henry and Klimkait, Thomas and Weisser, Maja and Labhardt, Niklaus Daniel. (2020) Genotype-Informed Versus Empiric Management Of VirEmia (GIVE MOVE): study protocol of an open-label randomised clinical trial in children and adolescents living with HIV in Lesotho and Tanzania. BMC infectious diseases, 20. p. 773.

De Pretto-Lazarova, Angela and Brancati-Badarau, Domnita Oana and Burri, Christian. (2020) Informed consent approaches for clinical trial participation of infants with minor parents in sub-Saharan Africa: a systematic review. PloS one, 15 (8). e0237088.

This list was generated on Thu Apr 18 03:48:34 2024 CEST.